106 related articles for article (PubMed ID: 21867871)
1. Echocardiographic assessment of fabry cardiomyopathy: early diagnosis and follow-up.
Pieroni M
J Am Soc Echocardiogr; 2011 Sep; 24(9):1033-6. PubMed ID: 21867871
[No Abstract] [Full Text] [Related]
2. Tei index in fabry disease.
Niemann M; Breunig F; Beer M; Hu K; Liu D; Emmert A; Herrmann S; Ertl G; Wanner C; Takenaka T; Tei C; Weidemann F
J Am Soc Echocardiogr; 2011 Sep; 24(9):1026-32. PubMed ID: 21719255
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic concordance of echocardiography and cardiac magnetic resonance-based tissue tracking for differentiating constrictive pericarditis from restrictive cardiomyopathy.
Amaki M; Savino J; Ain DL; Sanz J; Pedrizzetti G; Kulkarni H; Narula J; Sengupta PP
Circ Cardiovasc Imaging; 2014 Sep; 7(5):819-27. PubMed ID: 25107553
[TBL] [Abstract][Full Text] [Related]
4. Myocardial lipid content in Fabry disease: a combined
Petritsch B; Köstler H; Weng AM; Horn M; Gassenmaier T; Kunz AS; Weidemann F; Wanner C; Bley TA; Beer M
BMC Cardiovasc Disord; 2016 Oct; 16(1):205. PubMed ID: 27793097
[TBL] [Abstract][Full Text] [Related]
5. Multimodality Imaging Assessment of Fabry Disease.
Tower-Rader A; Jaber WA
Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009013. PubMed ID: 31718277
[TBL] [Abstract][Full Text] [Related]
6. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy.
Saccheri MC; Cianciulli TF; Challapa Licidio W; Lax JA; Beck MA; Morita LA; Gagliardi JA;
Echocardiography; 2018 May; 35(5):643-650. PubMed ID: 29457264
[TBL] [Abstract][Full Text] [Related]
7. Late gadolinium enhancement image masquerading as hypertrophic cardiomyopathy in Fabry disease receiving enzyme replacement therapy.
Yano T; Oshima H; Miki T; Tanaka M; Muranaka A; Osanami A; Takahashi F; Miura T
Int J Cardiol; 2016 Jan; 203():136-7. PubMed ID: 26512827
[No Abstract] [Full Text] [Related]
8. Prognostic Significance of Cardiac Magnetic Resonance Imaging Late Gadolinium Enhancement in Fabry Disease.
Hanneman K; Karur GR; Wasim S; Morel CF; Iwanochko RM
Circulation; 2018 Nov; 138(22):2579-2581. PubMed ID: 30571357
[No Abstract] [Full Text] [Related]
9. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography.
Cawley PJ; Hamilton-Craig C; Owens DS; Krieger EV; Strugnell WE; Mitsumori L; D'Jang CL; Schwaegler RG; Nguyen KQ; Nguyen B; Maki JH; Otto CM
Circ Cardiovasc Imaging; 2013 Jan; 6(1):48-57. PubMed ID: 23212272
[TBL] [Abstract][Full Text] [Related]
10. [Cardiological follow-up in patients with Fabry disease].
Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
[TBL] [Abstract][Full Text] [Related]
11. Two-dimensional and Doppler echocardiography reliably predict severe pulmonary regurgitation as quantified by cardiac magnetic resonance.
Renella P; Aboulhosn J; Lohan DG; Jonnala P; Finn JP; Satou GM; Williams RJ; Child JS
J Am Soc Echocardiogr; 2010 Aug; 23(8):880-6. PubMed ID: 20591618
[TBL] [Abstract][Full Text] [Related]
12. Assessment of diastolic dysfunction in patients with acute coronary syndrome and preserved systolic function: comparison between Doppler transthoracic echocardiography and velocity-encoded cardiac magnetic resonance.
Azarisman SM; Shirazi M; Bradley J; Teo KS; Worthley MI; Worthley SG
Acta Cardiol; 2016 Aug; 71(4):425-34. PubMed ID: 27594358
[No Abstract] [Full Text] [Related]
13. Heart Involvement in a Woman Treated with Hydroxychloroquine for Systemic Lupus Erythematosus Revealing Fabry Disease.
Chatre C; Filippi N; Roubille F; Pers YM
J Rheumatol; 2016 May; 43(5):997-8. PubMed ID: 27134281
[No Abstract] [Full Text] [Related]
14. Semiautomatic quantification of left ventricular function by two-dimensional feature tracking imaging echocardiography. A comparison study with cardiac magnetic resonance imaging.
Di Bella G; Zito C; Gaeta M; Cusmà Piccione M; Minutoli F; Donato R; Recupero A; Madaffari A; Coglitore S; Carerj S
Echocardiography; 2010 Aug; 27(7):791-7. PubMed ID: 20597953
[TBL] [Abstract][Full Text] [Related]
15. Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry disease.
Masarone D; Duro G; Dellegrottaglie S; Colomba P; Rubino M; Cirillo A; Pisani A; Caiazza M; Elliott PM; Calabrò P; Pacileo G; Limongelli G
Future Cardiol; 2017 Nov; 13(6):521-527. PubMed ID: 28936893
[TBL] [Abstract][Full Text] [Related]
16. Use of cardiovascular magnetic resonance imaging in the assessment of left ventricular function, scar and viability in patients with ischaemic cardiomyopathy and chronic myocardial infarction.
Beek AM; van Rossum AC
Heart; 2010 Sep; 96(18):1494-501. PubMed ID: 20813731
[No Abstract] [Full Text] [Related]
17. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
Niemann M; Herrmann S; Hu K; Breunig F; Strotmann J; Beer M; Machann W; Voelker W; Ertl G; Wanner C; Weidemann F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):592-601. PubMed ID: 21679893
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic Assessment of Patients with Fabry Disease.
Yeung DF; Sirrs S; Tsang MYC; Gin K; Luong C; Jue J; Nair P; Lee PK; Tsang TSM
J Am Soc Echocardiogr; 2018 Jun; 31(6):639-649.e2. PubMed ID: 29606333
[TBL] [Abstract][Full Text] [Related]
19. Multimodality imaging in Fabry cardiomyopathy: from early diagnosis to therapeutic targets.
Militaru S; Ginghina C; Popescu BA; Saftoiu A; Linhart A; Jurcut R
Eur Heart J Cardiovasc Imaging; 2018 Dec; 19(12):1313-1322. PubMed ID: 30247528
[TBL] [Abstract][Full Text] [Related]
20. Discrepancies in Left Ventricular Mass Calculation Based on Echocardiography and Cardiovascular Magnetic Resonance Measurements in Patients with Left Ventricular Hypertrophy.
Seo HY; Lee SP; Park JB; Lee JM; Park EA; Chang SA; Kim HK; Park SJ; Lee W; Kim YJ; Lee SC; Park SW; Sohn DW; Choe YH
J Am Soc Echocardiogr; 2015 Oct; 28(10):1194-1203, e2. PubMed ID: 26194306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]